Cite
Zhang J, Dierckx R, Mohee K, et al. Xanthine oxidase inhibition for the treatment of cardiovascular disease: an updated systematic review and meta-analysis. ESC Heart Fail. 2016;4(1):40-45doi: 10.1002/ehf2.12112.
Zhang, J., Dierckx, R., Mohee, K., Clark, A. L., & Cleland, J. G. (2017). Xanthine oxidase inhibition for the treatment of cardiovascular disease: an updated systematic review and meta-analysis. ESC heart failure, 4(1), 40-45. https://doi.org/10.1002/ehf2.12112
Zhang, Jufen, et al. "Xanthine oxidase inhibition for the treatment of cardiovascular disease: an updated systematic review and meta-analysis." ESC heart failure vol. 4,1 (2017): 40-45. doi: https://doi.org/10.1002/ehf2.12112
Zhang J, Dierckx R, Mohee K, Clark AL, Cleland JG. Xanthine oxidase inhibition for the treatment of cardiovascular disease: an updated systematic review and meta-analysis. ESC Heart Fail. 2017 Feb;4(1):40-45. doi: 10.1002/ehf2.12112. Epub 2016 Sep 20. PMID: 28217311; PMCID: PMC5292634.
Copy
Download .nbib